Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, Merus N.V. (MRUS) has a Wall Street consensus price target of $97.00, based on estimates from 22 covering analysts. With the stock currently trading at $90.00, this represents a potential upside of +7.8%. The company has a market capitalization of $6.83B.
Analyst price targets range from a low of $97.00 to a high of $97.00, representing a 0% spread in expectations. The median target of $97.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 10 analysts rating the stock as a Buy or Strong Buy,12 rating it Hold, and 0 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, MRUS trades at a trailing P/E of -26.9x. Analysts expect EPS to grow -11.5% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how MRUS stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus price target for MRUS is $97, close to the current price of $90 (7.8% implied move). Based on 22 analyst estimates, the stock appears fairly valued near current levels.
MRUS has a consensus rating of "Hold" based on 22 Wall Street analysts. The rating breakdown is mixed, with 12 Hold ratings making up the largest segment. The consensus 12-month price target of $97 implies 7.8% upside from current levels.
MRUS's current price is $90 with a consensus target of $97 (7.8% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
The most bullish Wall Street analyst has a price target of $97 for MRUS, while the most conservative target is $97. The consensus of $97 represents the median expectation. These targets typically reflect 12-month expectations.
MRUS is well covered by analysts, with 22 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 10 have Buy ratings, 12 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month MRUS stock forecast based on 22 Wall Street analysts shows a consensus price target of $97, with estimates ranging from $97 (bear case) to $97 (bull case). The median consensus rating is "Hold".
MRUS appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $97 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
MRUS analyst price targets range from $97 to $97, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $97 consensus represents the middle ground.